424 / | HD | DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS |
|
130.1 | | IMMUNOGLOBULIN, ANTISERUM, ANTIBODY, OR ANTIBODY FRAGMENT, EXCEPT CONJUGATE OR COMPLEX OF THE SAME WITH NONIMMUNOGLOBULIN MATERIAL {18} |
131.1 | DF | .~> Anti-idiotypic |
132.1 | DF | .~> Derived from transgenic multicellular eukaryote (e.g., plant, etc.) |
133.1 | DF | .~> Structurally-modified antibody, immunoglobulin, or fragment thereof (e.g., chimeric, humanized, CDR-grafted, mutated, etc.) {3} |
137.1 | DF | .~> Binds specifically-identified oligosaccharide structure |
138.1 | DF | .~> Binds expression product or fragment thereof of cancer-related gene (e.g., oncogene, proto-oncogene, etc.) |
139.1 | DF | .~> Binds antigen or epitope whose amino acid sequence is disclosed in whole or in part (e.g., binds specifically-identified amino acid sequence, etc.) |
140.1 | DF | .~> Extracorporeal or ex vivo removal of antibodies or immune complexes (e.g., removal of autoantibodies, etc.); or extracorporeal or ex vivo removal of antigen by antibodies (e.g., removal of cancer cells from bone marrow by antibodies, etc.) |
141.1 | DF | .~> Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) {8} |
157.1 | DF | .~> Derived from, or present in, food product (e.g., milk, colostrum, whey, eggs, etc.) |
158.1 | DF | .~> Binds hormone or other secreted growth regulatory factor, differentiation factor, or intercellular mediator (e.g., cytokine, vascular permeability factor, etc.); or binds serum protein, plasma protein, fibrin, or enzyme |
159.1 | DF | .~> Binds virus or component thereof {3} |
163.1 | DF | .~> Binds antigens of multiple bacterial species (e.g., multivalent antiserum that binds antigens of multiple bacterial species, etc.) |
164.1 | DF | .~> Binds bacterium or component thereof or substance produced by said bacterium {6} |
171.1 | DF | .~> Binds allergen or component thereof |
172.1 | DF | .~> Binds eukaryotic cell or component thereof or substance produced by said eukaryotic cell (e.g., honey, etc.) {2} |
175.1 | DF | .~> Binds hapten, hapten-carrier complex, or specifically-identified chemical structure (e.g., drug, etc.) |
176.1 | DF | .~> Free from infectious agents (e.g., viruses or bacteria removed or inactivated, etc.) |
177.1 | DF | .~> Reduced antigenicity, reduced ability to bind complement, or reduced numbers of activated complement components (e.g., free from aggregated, denatured, fragmented, or polymerized immunoglobulins; free from proteolytic enzymes, etc.) |